9th November 2016
Innovative biotechnology company, Axim Biotechnologies Inc has appointed Grayling in the US to support its Investor Relations and Public Relations’ needs.
Axim Biotechnologies is engaged in the research and development, and production of pharmaceutical, nutriceutical and cosmetic products, as well as the procurement of genetically and nano-controlled active ingredients. The company’s particular focus is on the development of treatments for pain, spasticity, anxiety and other medical disorders using cannabinoids-based products. Pharmaceutical R&D aims to deliver systems and active pharmaceutical ingredients for treating conditions such as Parkinson's disease, Alzheimer's disease, restless leg syndrome and Crohn's disease.
Presently, the company is conducting clinical studies of MedChewRx, a pharmaceutical chewing gum containing cannabinoids. The company is in the process of getting FDA and EMA regulatory approval to launch this product in 2017, and it is in regard to this that Grayling is providing support.
Grayling’s efforts will be driven by New York based executive vice president, Lucia Domville. She says: “This is a fascinating company that is really pushing the boundaries with its research, and we are thrilled to be their partner.”
22nd August 2017
Emerging trends in the professional services sector
There is no escaping the fact that in terms of public profile the next few years will be critical for the professional services sector, not least because of the current economic and political climate,...Read More
9th August 2017
CSR panel and networking event
Grayling Scotland is hosting a special panel event with networking and drinks on the subject of how CSR can support a company's reputation. A company's governance, positive influence on...Read More
7th August 2017
Grayling's Meakin to talk innovation at international comms summit
Grayling's global head of strategic services, Jon Meakin will join a roster of international speakers at the ICCO Global Summit, to be held in Helsinki on 5-6 October. With a theme of...Read More